3 Reasons Why an Early Toxicity Assessment Strategy is Important




Pharmaceuticals & Biotechnology | Pharma & Biotech Resources show

Summary: In this interview Jorge I. González Borroto, PhD, Senior Toxicologist, Pharmacology and Safety Department at Ferrer, speaks to Andrea Charles from Pharma IQ, about how the company forms their predictive toxicology strategy and the importance of an early toxicity